Nerve repair

Nerve repair is a multifaceted physiological process dedicated to restoring structural and functional integrity to damaged neurons, most effectively observed in the peripheral nervous system (PNS) [2, 3]. It involves a series of highly coordinated stages, including Wallerian degeneration, the activation and reprogramming of Schwann cells into a repair phenotype, and the elongation of axonal sprouts guided by the Bands of Büngner [2, 7, 9]. Rather than being a single molecular target like a receptor or enzyme, nerve repair is a therapeutic goal or biological area that relies on the orchestrated expression of various neurotrophic factors (e.g., NGF, BDNF), extracellular matrix proteins (e.g., laminin), and signaling cascades such as the PI3K/Akt and MEK/ERK pathways [2, 6, 22]. In drug development, the term encompasses diverse strategies ranging from small-molecule kinase inhibitors that foster intrinsic growth capacity to bioengineered scaffolds that provide mechanical and electrical cues to regenerating axons [5, 10, 23]. Because it lacks a specific protein identifier and represents a broad physiological outcome, it is classified as a therapeutic area or biological process rather than a discrete druggable target [3, 8, 14].

Other names

NeuroregenerationNerve regenerationAxonal repairNeural repairWallerian regeneration

Not applicable as a single target mechanism; therapeutic interventions generally work by activating neurotrophic signaling (e.g., PI3K/Trk pathways), inhibiting intrinsic growth blockers (e.g., ATM kinase or Nogo-A), or modulating the inflammatory and extracellular matrix environment to favor axonal elongation [5, 10, 21, 22].